Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2022.327 | Electroacupuncture with or without combined warm needling for tinnitus: a randomized, waitlist-controlled trial |
Prof. LIN Zhi-xiu 林志秀 |
| 2023.142 | Efficacy of soothing cream jel in improving the range of motion and chronic pain at shoulder and elbow: A Double-blinded, Randomized, Placebo-Controlled Trial (Chinese Title:舒緩凝膠在改善肩部和肘部的活動範圍和慢性疼痛方面的有效性：一項雙盲、隨機、安慰劑對照臨床試驗) | Prof. LIN Zhixiu |
| 2021.712 | Development of a Novel Chinese Medicine Formula for the Treatment of Psoriasis: A Randomized, Double-blinded, Placebo-controlled Trial Chinese Title: 臨床經驗中藥複方作為新型治療銀屑病製劑的研發：隨機、雙盲、安慰劑對照的臨床試驗 |
Prof. LIN Zhixiu 林志秀 |
| 2022.423 | A Randomized Placebo-Controlled Pilot Study of an Herbal Formula Modified Huang-Lian-Jie-Du Decoction (MHLJDD) for Atopic Dermatitis in Children |
Prof. LIN Zhixiu 林志秀 |
| 2022.477 | The Effectiveness and Safety of Qingyan Lihou Decoction for the Treatment of Chronic Pharyngolaryngitis: A Randomized, Double-blinded, Placebo-controlled Trial |
Prof. LIN Zhixiu 林志秀 |
| 2022.184 | Efficacy and Safety of an innovative Chinese Herbal formular for the Treatment of Gout: A Double-blind, Randomized, Placebo-Controlled Trial 一個創新中藥方劑作為治療痛風症之療效及安全性研究：隨機、雙盲、安慰劑對照臨床試驗 |
Prof. LIN Zhixiu 林志秀 |
| 2021.177 | Efficacy and Safety of an Innovative Chinese Herbal Formula for the Treatment of Macular Edema: A Double-blind, Randomized, Placebo-Controlled Trial Chinese Title: 一個創新中藥方劑治療黃斑水腫療效和安全性的雙盲、隨機、安慰劑對照臨床研究 |
Prof. LIN Zhixiu 林志秀 |
| 2021.125 | English Title: Chinese Medicine for Residue Symptoms of COVID-19 Recovered Patients – A Double-blind, Randomized, Placebo-controlled study Chinese Title: 中藥對2019冠狀病毒病康復者後遺症狀：雙盲、隨機、安慰劑對照臨床研究 |
Prof. LIN Zhixiu 林志秀 |
| 2021.469 | Efficacy and Safety of using Granule Dendrobii for the treatment of chronic Atrophic Gastritis in subjects with deficiency of Qi and Yin: a randomized, double-blind, parallel, placebo-controlled study Chinese title: 鐵皮楓斗顆粒治療慢性萎縮性胃炎（氣陰兩虛證）有效性和安全性的隨機、雙盲、安慰劑平行對照臨床試驗 |
Prof. LIN Zhixiu 林志秀 |
| 2021.085 | Efficacy and Safety of Modified Xiao-Feng Powder in the Treatment of Chronic Urticaria – A Double-Blind Randomized Placebo-Controlled Study |
Prof. LIN Zhixiu 林志秀 |
| 2022.278 | Yunzhi Essence to Improve the Quality of Life of Patients with Advanced Stage of Cancer: A Randomized, Double-blinded, Placebo-controlled Trial Chinese Title: 雲芝純提取物改善晚期癌症患者生活質量的隨機、雙盲、安慰劑對照臨床試驗 |
Prof. LIN Zhixiu 林志秀 |
| 2021.057 | The effects of using Yupingfeng Powder with variation for the treatment of allergic rhinitis (AR): a randomized controlled trial |
Prof. LIN Zhixiu 林志秀 |
| 2022.345 | The Safety and Effects of using Shuiniujiao Dihuang Decoction with Variation for the Treatment of Psoriasis: A Double-blind, Randomized, Placebo-Controlled Trial Chinese Title: 臨床經驗中藥複方「涼血消銀方」治療銀屑病的隨機、雙盲、安慰劑對照臨床試驗 |
Prof. LIN Zhixiu 林志秀 |
| 2024.066 | Efficacy and Safety of Modified Suan ZaoRen Tang-TianWang BuXin Dan in the Treatment of Chronic Insomnia: A Randomized, Double-blinded, Placebo-controlled Trial |
Prof. LIN Zhixiu 林志秀 |
| 2023.299 | Effectiveness and Safety of Shaoyao Gancao Decoction with Addition on the Sleep-related Leg Cramps: A Randomized, Double-Blinded, Placebo-Controlled Trial |
Prof. LIN Zhixiu 林志秀 |
| 2019.538 | The therapeutic effect of a combined therapy of Tui-na and oral Chinese medicine on Osteoarthritis of Knee - A randomized wait-list controlled trial |
Prof. LIN Zhixiu 林志秀 |
| 2020.045 | A pragmatic trial using Chinese medicine practitioner’s approach to improve ALBI score on the patients diagnosed with Child-Pugh B or C hepatocellular carcinoma |
Prof. LIN Zhixiu 林志秀 |
| 2019.142 | A Randomized Placebo-Controlled Clinical Trial of an Innovative Herbal Formula for Atopic Dermatitis in Children: Evaluations of Modified Qing-Ying Decoction on Efficacy and Gut Microbiome | Prof. LIN Zhixiu |
| 2019.639 | Efficacy of Uncaria Rhynchophylla (Gou-Teng) for Patients with Mild Cognitive Impairment: A Pilot Randomized Controlled Trial Using White Matter Hyperintensities Estimated by ARIA as Outcome |
Prof. LIN Zhixiu 林志秀 |
| 2024.496 | Efficacy and Safety of Dachaihu Decoction Combined Erzhiwan with Variation for the Treatment of Hypercholesterolemia: A Parallel, Randomized, Double-blinded, Placebo-controlled Trial 大柴胡湯聯合二至丸加減方治療高膽固醇血症的有效性與安全性：一項平行、隨機、雙盲、安慰劑對照臨床試驗 | Prof. LIN Zhixiu |
| 2024.623 | Modified Huang-Lian-Jie-Du Decoction for the Treatment of Atopic Dermatitis: A Randomized Placebo-Controlled Trial on Its Efficacy and Impact on Gut Microbiome Chinese Title:黃連解毒湯優化方(MHLJDD)治療特應性皮炎療效及對腸道微生物組影響的雙盲、隨機、安慰劑對照臨床研究 | Prof. LIN Zhixiu |
| 2024.191 | The effects of using Yupingfeng Powder with variation for the treatment of allergic rhinitis (AR): a randomized controlled trial |
Prof. LIN Zhixiu 林志秀 |
| 2021.351 | Cross-cultural adaptation and validation of the Victorian Institute of Sport Assessment-Patellar (VISA-P) questionnaire for Chinese population with Patellar Tendinopathy | Dr. LING Samuel Ka-Kin |
| 2021.169 | RCT of magnesium cream vs analgesic balm to control bunion pain |
Dr. LING Ka Kin Samuel 凌家健 |
| 2021.051 | The effect of an injury prevention exercise programme for pre-professional dancers: A randomised controlled trial |
Dr. LING Ka Kin Samuel 凌家健 |
| 2016.187 | Household-based environmental behaviour change communication intervention to improve plastic waste management practices (C-PASTE) in rural Guizhou: a pilot randomised controlled trial |
Mr. LING Kelvin Wai Kit 凌偉傑 |
| 2021.649 | Impact of COVID-19 on Lung Function and 6-minute Walk over 1 Year in COVID-19 Convalescents |
Mr. LING Kwun Cheung 練觀祥 |
| 2023.315 | Characterization of immune cell subsets and single-cell multi-omics analysis in sepsis: a prospective observational study in the ICU | Dr. LING Lo Well |
| 2022.444 | Genetics Of Mortality In Critical Care (GenOMICC) | Dr LING Lowell |
| 2021.026 | Outcomes of patients with COVID-19 admitted to Intensive Care Units in Hong Kong | Prof. LING Lowell |
| 2022.620 | Retrospective Analysis on Pathogen Detection of Respiratory FilmArray | Dr. LING Lowell |
| 2022.376 | Longitudinal leukocyte adhesive function assay in sepsis and non-infectious inflammation: a prospective observational study in the ICU | Dr. LING Lowell |
| 2023.607 | Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in Adults with Sepsis: A Feasibility Study for a Multicenter Double-Blind Randomized Placebo-Controlled Trial | Dr. LING Lowell |
| 2024.040 | Electronic health record-based sepsis surveillance to estimate pediatric sepsis incidence and mortality in Hong Kong | Dr. LING Lowell |
| 2022.224 | Longitudinal trends in outcomes of extracorporeal membrane oxygenation: a territory-wide observational study | Dr. LING Lowell |
| 2021.345 | Wearable Bioimpedance Analyzer For Continuous Blood Pressure Monitoring Powered by Highly Flexible Solid-State Batteries | Prof Ling Lowell |
| 2023.327 | Impact of Rapid pathogen detection in ICU patients with Suspected Pneumonia on Antimicrobial Therapy: a pilot, randomized, controlled open-label feasibility trial | Dr. LING Lowell |
| 2023.599 | A Clinically-Oriented Antimicrobial Resistance Surveillance Network for Healthcare-associated infections (ACORN-HAI) | Dr. LING Lowell |
| 2021.739 | Characterization of peptidoglycan in sepsis: a prospective observational study in the ICU | Dr. LING Lowell |
| 2025.012 | Public health impact of antimicrobial resistance bacterial infections and inappropriate antimicrobial therapy in Hong Kong: 16-year longitudinal study | Dr. LING Lowell |
| 2024.163 | Clinical phenotypes and outcomes in patients with acute respiratory failure caused by COVID-19 associated with different variants of concern: A territory-wide study in Hong Kong | Dr. LING Lowell |
| 2024.398 | Adjunctive Fludrocortisone in Septic Shock: a multicenter, double-blind, randomized, placebo-controlled pilot trial (AFLUDROS-1) | Dr LING Lowell |
| 2020.517 | Cause and management of air in ECMO circuit: a retrospective case series | Dr. LING Lowell |
| 2019.351 | Management and Outcome of Traumatic Brain Injury, Observational Registry (MOTOR Study) | Dr. LING Lowell |
| 2019.543 | Pneumonia dosing in critically ill patients: a prospective cohort study | Dr. LING Lowell |
| 2019.581 | Epidemiology and determinants of outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care (EUROBACT II) | Dr. LING Lowell |
| 2019.214 | Incidence and Outcomes of Sepsis in Hong Kong: a population based study between 2009 and 2019 | Dr. LING Lowell |
| 2019.372 | Genomic approaches for predicting severity of organ dysfunction and outcomes in sepsis: a prospective cohort study in adult critically ill patients with sepsis |
Dr. LING Lowell 凌若崴 |
| 2019.635 | Incidence of Multidrug Resistant Organisms in ICU: a multicenter retrospective study | Dr. LING Lowell |
| 2018.287 | Genome wide expression in infection and sepsis: a pilot prospective cohort study |
Dr. LING Lowell 凌若崴 |
Page 154 of 262.